Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2019)
Quality ID #468 (NQF 3175): Continuity of Pharmacotherapy for Opioid Use Disorder (OUD)
M. Haddad, Alexei Zelenev, F. Altice (2013)
Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes.Drug and alcohol dependence, 131 1-2
Sarah Haight, Jean Ko, Van Tong, Michele Bohm, W. Callaghan (2018)
Opioid Use Disorder Documented at Delivery Hospitalization — United States, 1999–2014Morbidity and Mortality Weekly Report, 67
SC Haight, JY Ko, VT Tong, MK Bohm, WM Callaghan (2018)
Opioid use disorder documented at delivery hospitalization - United States, 1999?2014MMWR Morb Mortal Wkly Rep, 67
Hillary Samples, A. Williams, S. Crystal, M. Olfson (2020)
Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid.Health affairs, 39 5
H. Jones, K. Kaltenbach, Tara Benjamin, E. Wachman, K. O’grady (2019)
Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions.Journal of Addiction Medicine
C. Timko, Nicole Schultz, Michael Cucciare, Lisa Vittorio, Christina Garrison-Diehn (2016)
Retention in medication-assisted treatment for opiate dependence: A systematic reviewJournal of Addictive Diseases, 35
K. Kaltenbach, K. O’grady, S. Heil, Amy Salisbury, M. Coyle, G. Fischer, Peter Martin, S. Stine, H. Jones (2018)
Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes.Drug and alcohol dependence, 185
(2012)
ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy.Obstetrics and gynecology, 119 5
Ashley Leech, W. Cooper, Elizabeth McNeer, T. Scott, S. Patrick (2020)
Neonatal Abstinence Syndrome In The United States, 2004-16.Health affairs, 39 5
W. Lo‐Ciganic, J. Donohue, J. Kim, E. Krans, B. Jones, D. Kelley, A. James, M. Jarlenski (2018)
Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United StatesPharmacoepidemiology and Drug Safety, 28
(2012)
The New England Journal of Medicine
M. Jarlenski, Nicole Paul, E. Krans (2020)
Polysubstance Use Among Pregnant Women With Opioid Use Disorder in the United States, 2007-2016.Obstetrics & Gynecology
Stacey Klaman, K. Isaacs, A. Leopold, Joseph Perpich, S. Hayashi, J. Vender, Melinda Campopiano, H. Jones (2017)
Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National GuidanceJournal of Addiction Medicine, 11
Jean Ko, S. Patrick, Van Tong, Roshni Patel, Jennifer Lind, W. Barfield (2016)
Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013.MMWR. Morbidity and mortality weekly report, 65 31
W. Lo‐Ciganic, W. Gellad, A. Gordon, Gerald Cochran, M. Zemaitis, T. Cathers, D. Kelley, J. Donohue (2016)
Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization.Addiction, 111 5
Davida Schiff, Timothy Nielsen, M. Terplan, Malena. Hood, Dana Bernson, Hafsatou Diop, M. Bharel, T. Wilens, Marc Larochelle, A. Walley, T. Land (2018)
Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts.Obstetrics and gynecology, 132 2
M. Behnke, V. Smith (2013)
Prenatal Substance Abuse: Short- and Long-term Effects on the Exposed FetusPediatrics, 131
K Kampman, M Jarvis (2015)
National practice guideline for the use of medications in the treatment of addiction involving opioid useJAddict Med, 9
Substance Abuse and Mental Health Services Administration. Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants
J. Salemi, S. Raza, Sanjukta Modak, Jo Fields-Gilmore, Maria Grubb, R. Zoorob (2020)
The association between use of opiates, cocaine, and amphetamines during pregnancy and maternal postpartum readmission in the United States: A retrospective analysis of the Nationwide Readmissions Database.Drug and alcohol dependence, 210
JY Ko, S Wolicki, WD Barfield (2017)
CDC Grand Rounds: Public health strategies to prevent neonatal Abstinence syndromeMMWR Morb Mortal Wkly Rep, 66
Jennifer Lind, E. Ailes, C. Alter, J. Fornoff, Peggy Brozicevic, Luigi Saavedra, L. Tomedi, Melissa Gambatese, Barbara Carroll, Lucia Orantes, Brennan Martin, Ashley Horne, J. Reefhuis (2019)
Leveraging Existing Birth Defects Surveillance Infrastructure to Build Neonatal Abstinence Syndrome Surveillance Systems — Illinois, New Mexico, and Vermont, 2015–2016Morbidity and Mortality Weekly Report, 68
J. Gryczynski, S. Mitchell, J. Jaffe, K. O’grady, Y. Olsen, R. Schwartz (2014)
Leaving buprenorphine treatment: patients' reasons for cessation of care.Journal of substance abuse treatment, 46 3
H. Jones, K. Kaltenbach, S. Heil, S. Stine, M. Coyle, A. Arria, K. O’grady, P. Selby, Peter Martin, G. Fischer (2010)
Neonatal abstinence syndrome after methadone or buprenorphine exposure.The New England journal of medicine, 363 24
M. Terplan, H. Laird, Dennis Hand, T. Wright, Ashish Premkumar, C. Martin, M. Meyer, H. Jones, E. Krans (2018)
Opioid Detoxification During Pregnancy: A Systematic Review.Obstetrics & Gynecology
J. Saunders, M. Jarlenski, Robert Levy, K. Kozhimannil (2017)
Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges.Women's health issues : official publication of the Jacobs Institute of Women's Health, 28 2
Lauren Adams, Susan Kennedy, L. Allen, Andrew Barnes, Tom Bias, D. Crane, P. Lanier, Rachel Mauk, Shamis Mohamoud, Nathan Pauly, J. Talbert, C. Woodcock, K. Zivin, J. Donohue (2019)
Innovative Solutions for State Medicaid Programs to Leverage Their Data, Build Their Analytic Capacity, and Create Evidence-Based PolicyeGEMs, 7
E. Krans, Gerald Cochran, D. Bogen (2015)
Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care ConsiderationsClinical Obstetrics and Gynecology, 58
L. Admon, G. Bart, K. Kozhimannil, C. Richardson, V. Dalton, T. Winkelman (2019)
Amphetamine- and Opioid-Affected Births: Incidence, Outcomes, and Costs, United States, 2004-2015.American journal of public health
M. Jarlenski, Elizabeth Krans, Joo Kim, Julie Donohue, A. James, D. Kelley, Bradley Stein, Debra Bogen (2020)
Five-Year Outcomes Among Medicaid-Enrolled Children With In Utero Opioid Exposure.Health affairs, 39 2
JN Lind, EC Ailes, CC Alter (2019)
Leveraging existing birth defects surveillance infrastructure to build neonatal abstinence syndrome surveillance systems - Illinois, New Mexico, and Vermont, 2015?2016MMWR Morb Mortal Wkly Rep, 68
(2018)
Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants
(2020)
Well-Child Visits in the First 15 Months of Life
Davida Schiff, M. Grossman (2019)
Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant.Seminars in fetal & neonatal medicine, 24 2
H. Salihu, M. Mogos, A. Salinas-Miranda, J. Salemi, V. Whiteman (2014)
National Trends in Maternal Use of Opioid Drugs among Pregnancy-Related Hospitalizations in the United States, 1998 to 2009American Journal of Perinatology, 32
J. Iglehart (2001)
The Centers for Medicare and Medicaid Services.The New England journal of medicine, 345 26
K. Kampman, Margaret Jarvis (2015)
American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid UseJournal of Addiction Medicine, 9
Drug Overdose Death Data
T. Winkelman, Nicole Villapiano, K. Kozhimannil, Matthew Davis, S. Patrick (2018)
Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004–2014Pediatrics, 141
H. Jones, G. Fischer, S. Heil, K. Kaltenbach, Peter Martin, M. Coyle, P. Selby, S. Stine, K. O’grady, A. Arria (2012)
Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned.Addiction, 107 Suppl 1
Patricia Yam, Laverne Lok, J. Eastwood, Catherine Maher, M. Ward, Sara Clews, J. Falconer, J. Oei (2019)
Validation of hospital discharge coding for neonatal abstinence syndromeActa Paediatrica, 108
Nicole Villapiano, T. Winkelman, K. Kozhimannil, Matthew Davis, S. Patrick (2017)
Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013JAMA Pediatrics, 171
JY Ko, SW Patrick, VT Tong, R Patel, JN Lind, WD Barfield (2016)
Incidence of neonatal abstinence syndrome - 28 States, 1999?2013MMWR Morb Mortal Wkly Rep, 65
D. Coviello, J. Cornish, K. Lynch, T. Boney, C. Clark, Joshua Lee, P. Friedmann, E. Nunes, T. Kinlock, M. Gordon, R. Schwartz, E. Nuwayser, C. O'brien (2012)
A Multisite Pilot Study of Extended-Release Injectable Naltrexone Treatment for Previously Opioid-Dependent Parolees and ProbationersSubstance Abuse, 33
Includes children diagnosed with NOWS by age 12 months and who remained continuously enrolled in Medicaid from birth through age 15 months
J. Martin, B. Hamilton, M. Osterman, A. Driscoll, Patrick Drake (2018)
Births: Final Data for 2016.National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, 67 1
Jean Ko, S. Wolicki, W. Barfield, S. Patrick, C. Broussard, K. Yonkers, Rebecca Naimon, J. Iskander (2017)
CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence SyndromeMorbidity and Mortality Weekly Report, 66
M. Jarlenski, E. Krans, Qingwen Chen, S. Rothenberger, Abigail Cartus, K. Zivin, L. Bodnar (2020)
Substance use disorders and risk of severe maternal morbidity in the United States.Drug and alcohol dependence, 216
E. Krans, J. Kim, A. James, D. Kelley, M. Jarlenski (2019)
Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder.Obstetrics & Gynecology
Author manuscript; available in PMC
Lisa Clemans-Cope, Victoria Lynch, E. Howell, I. Hill, N. Holla, J. Morgan, Paul Johnson, Caitlin Cross-Barnet, J. Thompson (2019)
Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.Drug and alcohol dependence, 195
Melonie Heron (2019)
Deaths: Leading Causes for 2017.National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, 68 6
Distribution of well-child visits in the first 15 months of live among children who had NOWS diagnosis, 9 state Medicaid programs
Supplemental Digital Content is available in the text
Journal of Addiction Medicine – Wolters Kluwer Health
Published: Sep 5, 2021
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.